| Document and Entity Information (USD $) | 3 Months Ended | |
| Mar. 31, 2015 | Jun. 30, 2014 | |
| Document and Entity Information: | ||
| Entity Registrant Name | PROTECT PHARMACEUTICAL Corp | |
| Document Type | 10-Q | |
| Document Period End Date | 31-Mar-15 | |
| Amendment Flag | FALSE | |
| Entity Central Index Key | 1493526 | |
| Current Fiscal Year End Date | -19 | |
| Entity Common Stock, Shares Outstanding | 110,959 | |
| Entity Public Float | $110,959 | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Current Reporting Status | No | |
| Entity Voluntary Filers | No | |
| Entity Well-known Seasoned Issuer | No | |
| Document Fiscal Year Focus | 2015 | |
| Document Fiscal Period Focus | Q1 |
| Balance Sheets (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
| ASSETS | ||
| Cash | $357 | $502 |
| Total Current Assets | 357 | 502 |
| TOTAL ASSETS | 357 | 502 |
| Accounts payable and accrued expenses | 63,720 | 63,433 |
| Related party payables | 61,702 | 58,052 |
| Total Current Liabilities | 125,422 | 121,485 |
| TOTAL LIABILITIES | 125,422 | 121,485 |
| Common stock; 100,000,000 shares authorized,at $0.005 par value, 106,259 and 89,459shares issued and outstanding, respectively | 531 | 447 |
| Additional paid-in capital | 8,594,814 | 8,593,398 |
| Deficit accumulated during the development stage | -8,720,410 | -8,714,828 |
| Total Stockholders' Deficit | -125,065 | -120,983 |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $357 | $502 |
| Statements of Operations (USD $) | 3 Months Ended | |
| Mar. 31, 2015 | Mar. 31, 2014 | |
| REVENUES | ||
| Professional Fees | $3,938 | $495 |
| Executive compensation | 1,500 | 1,500 |
| General and administrative | 144 | 45 |
| LOSS FROM OPERATIONS | -5,582 | -2,040 |
| LOSS BEFORE DISCONTINUED OPERATIONS | -5,582 | -2,040 |
| NET INCOME (LOSS) | ($5,582) | ($2,040) |
| BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK | ($0.06) | ($0.05) |
| WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING | 93,379 | 44,573 |
| Statements of Cash Flows (USD $) | 3 Months Ended | |
| Mar. 31, 2015 | Mar. 31, 2014 | |
| OPERATING ACTIVITIES | ||
| Net loss | ($5,582) | ($2,040) |
| Services contributed by an officer | 1,500 | 1,500 |
| Expenses paid on behalf of the Company | 3,650 | |
| Accounts payable | 287 | 495 |
| Net Cash Used in Operating Activities | -145 | -45 |
| NET CHANGE IN CASH | -145 | -45 |
| CASH AT BEGINNING OF PERIOD | 502 | 681 |
| CASH AT END OF PERIOD | $357 | $636 |
| Note 1 - Condensed Financial Statements | 3 Months Ended |
| Mar. 31, 2015 | |
| Notes | |
| Note 1 - Condensed Financial Statements | NOTE 1 - CONDENSED FINANCIAL STATEMENTS |
| The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at March 31, 2015, and for all periods presented herein, have been made. | |
| Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's December 31, 2014 audited financial statements. The results of operations for the periods ended March 31, 2015 and 2014 are not necessarily indicative of the operating results for the full years. |
| Note 2 - Going Concern | 3 Months Ended |
| Mar. 31, 2015 | |
| Notes | |
| Note 2 - Going Concern | NOTE 2 - GOING CONCERN |
| The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company does not have significant cash or other material assets, nor does it have an established source of revenues sufficient to cover its operating costs and to allow it to continue as a going concern. It is the intent of the Company to seek a merger with an existing, operating company. In the interim, shareholders of the Company have committed to meeting its minimal operating expenses |
| Note 3 - Significant Accounting Policies | 3 Months Ended |
| Mar. 31, 2015 | |
| Notes | |
| Note 3 - Significant Accounting Policies | NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES |
| Use of Estimates | |
| The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. | |
| Basic (Loss) per Common Share | |
| Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of March 31, 2015 and 2014. | |
| Recent Accounting Pronouncements | |
| In June 2014, the FASB issued ASU 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation”. The guidance eliminates the definition of a development stage entity thereby removing the incremental financial reporting requirements from U.S. GAAP for development stage entities, primarily presentation of inception to date financial information. The provisions of the amendments are effective for annual reporting periods beginning after December 15, 2014, and the interim periods therein. However, early adoption is permitted. Accordingly, the Company has adopted this standard as of March 31, 2015. | |
| Management has considered all other recent accounting pronouncements issued since the last audit of the Company’s financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements. |
| Note 4 - Related-party Transactions | 3 Months Ended |
| Mar. 31, 2015 | |
| Notes | |
| Note 4 - Related-party Transactions | NOTE 4 – RELATED-PARTY TRANSACTIONS |
| The Company has recorded advances from related parties and expenses paid by related parties on behalf of the Company as related party payables. As of March 31, 2015 and December 31, 2014, respectively, the related party payable outstanding balance totaled $61,702 and $58,052, respectively. These payables are non-interest bearing, unsecured, and are due on demand. | |
| Contributed Capital | |
| During the three months ended March 31, 2015 and 2014, a related-party has contributed various administrative services to the Company. These services have been valued at $1,500 for the three month periods then ended. In addition, during the year ended December 31, 2014 a related-party entity paid $10,000 toward accounts payable related parties held by the Company. |
| Note 5 - Stockholders' Equity | 3 Months Ended |
| Mar. 31, 2015 | |
| Notes | |
| Note 5 - Stockholders' Equity | NOTE 5 – STOCKHOLDERS’ EQUITY |
| On September 19, 2014, the Company issued 26,000 shares of common stock to Blue Cap Development Corp. in exchange for certain mining and/or mineral claims and/or leases located in New Mexico. Two principals of Blue Cap, Edward F. Cowle and H. Deworth Williams, are principal stockholders of the Company. | |
| On November 4, 2014, the Company effected a reverse stock split of its issued and outstanding shares of common stock on a one (1) share for one thousand (1000) shares basis. As per the terms of the reverse stock split, any fractional share amount resulting from the split was automatically rounded up to the next higher whole share amount, with the provision that no individual stockholder’s holdings would be reduced below 100 shares. Additional shares to restore each such affected stockholder’s holdings to 100 shares were issued, with certain shares issued during the 2014 calendar year, and the remainder issued during the three months ended March 31, 2015. The par value of the common stock remains at $0.005 per share. As a result of the reverse stock split and the rounding up of odd lots to 100 shares, at March 31, 2015, there were 106,259 shares certificated and outstanding. | |
| Note 6 - Significant Events | 3 Months Ended |
| Mar. 31, 2015 | |
| Notes | |
| Note 6 - Significant Events | NOTE 6 – SIGNIFICANT EVENTS |
| On February 6, 2009, the Company entered into a Patent Acquisition Agreement, whereby it was assigned various patents for pharmaceutical products in exchange for 7,000,000 shares of the Company’s common stock. Pursuant to the Agreement, 5,000,000 shares were delivered immediately to the assignor and 2,000,000 shares were held to be delivered upon the successful completion of $2,000,000 financing. The patents were also subject to a 20% royalty on revenues, a 10% milestone payment and an Executive Employment Agreement. The Company was responsible for the completion of a development program to commercialize products using the patented technologies within five years of the Agreement date. | |
| The Executive Employment Agreement provided that the patent holder would become the Company’s Chief Operating Officer. The agreement provided for an annual salary $250,000 in year one, $300,000 in year two and $350,000 in year three. The agreement also provided for compensatory common stock purchase warrants to be issued at not less than 20% of the shares issued for financing and other standard employee benefits. In January, 2013, the Chief Operating Officer resigned and the employment agreement expired, leaving a remaining balance owing in accrued officer salaries of $486,826 on the balance sheet at December 31, 2013. | |
| During the year ended December 31, 2014, this accrued officer salary and $2,167 of accrued expenses owed to this former officer was forgiven, resulting in a gain on forgiveness of debt in the amount of $488,993. |
| Note 7 - Subsequent Events | 3 Months Ended |
| Mar. 31, 2015 | |
| Notes | |
| Note 7 - Subsequent Events | NOTE 7 – SUBSEQUENT EVENTS |
| In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report. |
| Note 3 - Significant Accounting Policies: Use of Estimates (Policies) | 3 Months Ended |
| Mar. 31, 2015 | |
| Policies | |
| Use of Estimates | Use of Estimates |
| The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
| Note 3 - Significant Accounting Policies: Basic (loss) Per Common Share (Policies) | 3 Months Ended |
| Mar. 31, 2015 | |
| Policies | |
| Basic (loss) Per Common Share | Basic (Loss) per Common Share |
| Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of March 31, 2015 and 2014. |
| Note 3 - Significant Accounting Policies: Recent Accounting Pronouncements (Policies) | 3 Months Ended |
| Mar. 31, 2015 | |
| Policies | |
| Recent Accounting Pronouncements | Recent Accounting Pronouncements |
| In June 2014, the FASB issued ASU 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation”. The guidance eliminates the definition of a development stage entity thereby removing the incremental financial reporting requirements from U.S. GAAP for development stage entities, primarily presentation of inception to date financial information. The provisions of the amendments are effective for annual reporting periods beginning after December 15, 2014, and the interim periods therein. However, early adoption is permitted. Accordingly, the Company has adopted this standard as of March 31, 2015. | |
| Management has considered all other recent accounting pronouncements issued since the last audit of the Company’s financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements. |
